Pacira Sues WhiteOak, Qilu for Exparel Patent Infringement
Pacira BioSciences has filed patent infringement suits in the U.S. District Court for Delaware against The WhiteOak Group and...
Jon Napitupulu
Hutchmed Reveals New Clinical Data at ESMO & ASH Meetings
HUTCHMED will deliver a coordinated slate of oncology and hematology readouts across ESMO Asia and ASH in early December,...
Dipharma’s Novel Research on Nitrosamine Detection in APIs
Dipharm a Francis has published an open-access method in Organic Process Research & Development that integrates the nitrosation assay...
Valneva Chikungunya Vaccine Positive in Kids’ Phase 2 Trial
Valneva reported final 12-month antibody persistence and safety results from its Phase 2 pediatric study of IXCHIQ, its single-shot...
Bioversys Launches Promising Phase 3 Trial for BV100 Drug
BioVersys has initiated a global Phase 3 program for BV100 in ventilator- and hospital-acquired bacterial pneumonia caused by drug-resistant...
Clearmind Medicine Announces 1-for-40 Reverse Share Split
Clearmind Medicine will execute a 1‑for‑40 reverse share split on December 15, 2025, aiming to regain compliance with Nasdaq’s...
VERU Announcing FY2025 Financial Results on December 17th
Veru has set a Q1 2026 start for its Phase 2b Plateau study evaluating enobosarm, a selective androgen receptor...
Telix and Varian Announce Strategic Theranostics Collaboration
Telix Pharmaceuticals has entered a strategic clinical collaboration with Varian, a Siemens Healthineers company, to integrate Telix’s theranostic imaging...
Scilex Holding Closes Warrant Exercise for $20.3M Proceeds
Scilex Holding Company has closed an inducement financing built around existing warrants, securing approximately $20.3 million in gross proceeds....
Amphista Announces New AMX-883 Data, Business Update at ASH
Amphista Therapeutics will present new preclinical data at ASH 2025 for AMX-883, an oral targeted glue degrader of BRD9,...